Early response to neoadjuvant chemotherapy can help predict long-term survival in patients with cervical cancer

It is still controversial whether cervical cancer patients with clinical responses after neoadjuvant chemotherapy (NACT) have a better long-term survival or not. This study was designed to investigate the effect of the clinical response on the disease-free survival (DFS) of cervical cancer patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiong, Huang, Kecheng, Zhang, Qinghua, Shen, Jian, Zhou, Hang, Yang, Runfeng, Wang, Lin, Liu, Jiong, Zhang, Jincheng, Sun, Haiying, Jia, Yao, Du, Xiaofang, Wang, Haoran, Deng, Song, Ding, Ting, Jiang, Jingjing, Lu, Yunping, Li, Shuang, Wang, Shixuan, Ma, Ding
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350004/
https://www.ncbi.nlm.nih.gov/pubmed/27557523
http://dx.doi.org/10.18632/oncotarget.11460

Ejemplares similares

Ejemplares similares